Variant report
Variant | esv3392614 |
---|---|
Chromosome Location | chr6:64999684-65002578 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116510104 | chr6:64999701-64999702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555494240 | chr6:64999725-64999726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549396992 | chr6:64999744-64999745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558507901 | chr6:64999763-64999764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544329535 | chr6:64999769-64999770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555849183 | chr6:64999809-64999810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180790983 | chr6:64999821-64999822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567857603 | chr6:64999826-64999827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546154945 | chr6:64999858-64999859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs973266 | chr6:64999871-64999872 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs528672357 | chr6:64999876-64999877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187397557 | chr6:64999880-64999881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561943503 | chr6:64999889-64999890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116393399 | chr6:64999933-64999934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1922958 | chr6:64999964-64999965 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs192249129 | chr6:65000009-65000010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181798680 | chr6:65000012-65000013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149787438 | chr6:65000019-65000020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs566730316 | chr6:65000055-65000056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533977626 | chr6:65000062-65000063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549244100 | chr6:65000088-65000089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113929568 | chr6:65000099-65000100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372330478 | chr6:65000119-65000120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557577988 | chr6:65000156-65000157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537970214 | chr6:65000212-65000213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556199739 | chr6:65000235-65000236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115667960 | chr6:65000319-65000320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538590351 | chr6:65000346-65000347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560452923 | chr6:65000367-65000368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558171629 | chr6:65000394-65000395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186099814 | chr6:65000406-65000407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573249454 | chr6:65000420-65000421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540516001 | chr6:65000436-65000437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7753480 | chr6:65000452-65000453 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs368258258 | chr6:65000528-65000529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377081993 | chr6:65000540-65000541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368754684 | chr6:65000546-65000547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369048862 | chr6:65000550-65000551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78504253 | chr6:65000572-65000573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562965199 | chr6:65000573-65000574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533181016 | chr6:65000602-65000603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551704908 | chr6:65000636-65000637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7758780 | chr6:65000666-65000667 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs114745592 | chr6:65000692-65000693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369818704 | chr6:65000697-65000698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567494414 | chr6:65000787-65000788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148500974 | chr6:65000794-65000795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7759081 | chr6:65000821-65000822 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs113531045 | chr6:65000857-65000858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147860367 | chr6:65000859-65000860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:64998600-65003000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr6:65000600-65001200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr6:65000800-65001400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr6:65001200-65004400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:65001400-65001800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:65001800-65002200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr6:65002000-65002400 | Enhancers | Fetal Intestine Small | intestine |
8 | chr6:65002000-65004400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |